Molecular Residual Disease detection in early stage breast cancer with a personalized sequencing approach
Personalized circulating tumor DNA analysis in head and neck squamous cell carcinoma: preliminary results of the Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS) study
Resistance mechanisms to BRAF inhibition identified by single circulating tumor cell and cell-free tumor DNA molecular profiling in BRAF-mutant non-small-cell lung cancer
NTRK Fusions and Trk Proteins: What are They and How to Test for Them
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)
Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer
Circulating tumor DNA (ctDNA) clearance as a biomarker in patients with locally advanced NSCLC following chemoradiation
A highly sensitive and specific gene fusion algorithm based on multiple fusion callers and an ensemble machine learning approach